Acute Repetitive Seizures Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: AE72E330081AEN
Market Monitor Global

Abstracts

Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG.

This report contains market size and forecasts of Acute Repetitive Seizures in Global, including the following market information:

Global Acute Repetitive Seizures Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Acute Repetitive Seizures market was valued at 179.5 million in 2021 and is projected to reach US$ 1630.2 million by 2028, at a CAGR of 37.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

USL-261 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Acute Repetitive Seizures include UCB S.A., Neurelis, Valeant Pharmaceuticals North America LLC., Alexza Pharmaceuticals and Veriton Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Repetitive Seizures companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute Repetitive Seizures Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Acute Repetitive Seizures Market Segment Percentages, by Type, 2021 (%)

• USL-261
• NRL-1
• AZ-002
• Diastat Rectal Gel
• Others

Global Acute Repetitive Seizures Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Acute Repetitive Seizures Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Acute Repetitive Seizures Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Acute Repetitive Seizures Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Acute Repetitive Seizures revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Acute Repetitive Seizures revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• UCB S.A.
• Neurelis
• Valeant Pharmaceuticals North America LLC.
• Alexza Pharmaceuticals
• Veriton Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Acute Repetitive Seizures Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Acute Repetitive Seizures Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACUTE REPETITIVE SEIZURES OVERALL MARKET SIZE

2.1 Global Acute Repetitive Seizures Market Size: 2021 VS 2028
2.2 Global Acute Repetitive Seizures Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Acute Repetitive Seizures Players in Global Market
3.2 Top Global Acute Repetitive Seizures Companies Ranked by Revenue
3.3 Global Acute Repetitive Seizures Revenue by Companies
3.4 Top 3 and Top 5 Acute Repetitive Seizures Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acute Repetitive Seizures Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Repetitive Seizures Players in Global Market
  3.6.1 List of Global Tier 1 Acute Repetitive Seizures Companies
  3.6.2 List of Global Tier 2 and Tier 3 Acute Repetitive Seizures Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Acute Repetitive Seizures Market Size Markets, 2021 & 2028
  4.1.2 USL-261
  4.1.3 NRL-1
  4.1.4 AZ-002
  4.1.5 Diastat Rectal Gel
  4.1.6 Others
4.2 By Type - Global Acute Repetitive Seizures Revenue & Forecasts
  4.2.1 By Type - Global Acute Repetitive Seizures Revenue, 2017-2022
  4.2.2 By Type - Global Acute Repetitive Seizures Revenue, 2023-2028
  4.2.3 By Type - Global Acute Repetitive Seizures Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Acute Repetitive Seizures Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global Acute Repetitive Seizures Revenue & Forecasts
  5.2.1 By Application - Global Acute Repetitive Seizures Revenue, 2017-2022
  5.2.2 By Application - Global Acute Repetitive Seizures Revenue, 2023-2028
  5.2.3 By Application - Global Acute Repetitive Seizures Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Acute Repetitive Seizures Market Size, 2021 & 2028
6.2 By Region - Global Acute Repetitive Seizures Revenue & Forecasts
  6.2.1 By Region - Global Acute Repetitive Seizures Revenue, 2017-2022
  6.2.2 By Region - Global Acute Repetitive Seizures Revenue, 2023-2028
  6.2.3 By Region - Global Acute Repetitive Seizures Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Acute Repetitive Seizures Revenue, 2017-2028
  6.3.2 US Acute Repetitive Seizures Market Size, 2017-2028
  6.3.3 Canada Acute Repetitive Seizures Market Size, 2017-2028
  6.3.4 Mexico Acute Repetitive Seizures Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Acute Repetitive Seizures Revenue, 2017-2028
  6.4.2 Germany Acute Repetitive Seizures Market Size, 2017-2028
  6.4.3 France Acute Repetitive Seizures Market Size, 2017-2028
  6.4.4 U.K. Acute Repetitive Seizures Market Size, 2017-2028
  6.4.5 Italy Acute Repetitive Seizures Market Size, 2017-2028
  6.4.6 Russia Acute Repetitive Seizures Market Size, 2017-2028
  6.4.7 Nordic Countries Acute Repetitive Seizures Market Size, 2017-2028
  6.4.8 Benelux Acute Repetitive Seizures Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Acute Repetitive Seizures Revenue, 2017-2028
  6.5.2 China Acute Repetitive Seizures Market Size, 2017-2028
  6.5.3 Japan Acute Repetitive Seizures Market Size, 2017-2028
  6.5.4 South Korea Acute Repetitive Seizures Market Size, 2017-2028
  6.5.5 Southeast Asia Acute Repetitive Seizures Market Size, 2017-2028
  6.5.6 India Acute Repetitive Seizures Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Acute Repetitive Seizures Revenue, 2017-2028
  6.6.2 Brazil Acute Repetitive Seizures Market Size, 2017-2028
  6.6.3 Argentina Acute Repetitive Seizures Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Acute Repetitive Seizures Revenue, 2017-2028
  6.7.2 Turkey Acute Repetitive Seizures Market Size, 2017-2028
  6.7.3 Israel Acute Repetitive Seizures Market Size, 2017-2028
  6.7.4 Saudi Arabia Acute Repetitive Seizures Market Size, 2017-2028
  6.7.5 UAE Acute Repetitive Seizures Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 UCB S.A.
  7.1.1 UCB S.A. Corporate Summary
  7.1.2 UCB S.A. Business Overview
  7.1.3 UCB S.A. Acute Repetitive Seizures Major Product Offerings
  7.1.4 UCB S.A. Acute Repetitive Seizures Revenue in Global Market (2017-2022)
  7.1.5 UCB S.A. Key News
7.2 Neurelis
  7.2.1 Neurelis Corporate Summary
  7.2.2 Neurelis Business Overview
  7.2.3 Neurelis Acute Repetitive Seizures Major Product Offerings
  7.2.4 Neurelis Acute Repetitive Seizures Revenue in Global Market (2017-2022)
  7.2.5 Neurelis Key News
7.3 Valeant Pharmaceuticals North America LLC.
  7.3.1 Valeant Pharmaceuticals North America LLC. Corporate Summary
  7.3.2 Valeant Pharmaceuticals North America LLC. Business Overview
  7.3.3 Valeant Pharmaceuticals North America LLC. Acute Repetitive Seizures Major Product Offerings
  7.3.4 Valeant Pharmaceuticals North America LLC. Acute Repetitive Seizures Revenue in Global Market (2017-2022)
  7.3.5 Valeant Pharmaceuticals North America LLC. Key News
7.4 Alexza Pharmaceuticals
  7.4.1 Alexza Pharmaceuticals Corporate Summary
  7.4.2 Alexza Pharmaceuticals Business Overview
  7.4.3 Alexza Pharmaceuticals Acute Repetitive Seizures Major Product Offerings
  7.4.4 Alexza Pharmaceuticals Acute Repetitive Seizures Revenue in Global Market (2017-2022)
  7.4.5 Alexza Pharmaceuticals Key News
7.5 Veriton Pharma
  7.5.1 Veriton Pharma Corporate Summary
  7.5.2 Veriton Pharma Business Overview
  7.5.3 Veriton Pharma Acute Repetitive Seizures Major Product Offerings
  7.5.4 Veriton Pharma Acute Repetitive Seizures Revenue in Global Market (2017-2022)
  7.5.5 Veriton Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Acute Repetitive Seizures Market Opportunities & Trends in Global Market
Table 2. Acute Repetitive Seizures Market Drivers in Global Market
Table 3. Acute Repetitive Seizures Market Restraints in Global Market
Table 4. Key Players of Acute Repetitive Seizures in Global Market
Table 5. Top Acute Repetitive Seizures Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Acute Repetitive Seizures Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Acute Repetitive Seizures Revenue Share by Companies, 2017-2022
Table 8. Global Companies Acute Repetitive Seizures Product Type
Table 9. List of Global Tier 1 Acute Repetitive Seizures Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Repetitive Seizures Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Acute Repetitive Seizures Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Acute Repetitive Seizures Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Acute Repetitive Seizures Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Acute Repetitive Seizures Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Acute Repetitive Seizures Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Acute Repetitive Seizures Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Acute Repetitive Seizures Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Acute Repetitive Seizures Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Acute Repetitive Seizures Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Acute Repetitive Seizures Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Acute Repetitive Seizures Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Acute Repetitive Seizures Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Acute Repetitive Seizures Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Acute Repetitive Seizures Revenue, (US$, Mn), 2023-2028
Table 30. UCB S.A. Corporate Summary
Table 31. UCB S.A. Acute Repetitive Seizures Product Offerings
Table 32. UCB S.A. Acute Repetitive Seizures Revenue (US$, Mn), (2017-2022)
Table 33. Neurelis Corporate Summary
Table 34. Neurelis Acute Repetitive Seizures Product Offerings
Table 35. Neurelis Acute Repetitive Seizures Revenue (US$, Mn), (2017-2022)
Table 36. Valeant Pharmaceuticals North America LLC. Corporate Summary
Table 37. Valeant Pharmaceuticals North America LLC. Acute Repetitive Seizures Product Offerings
Table 38. Valeant Pharmaceuticals North America LLC. Acute Repetitive Seizures Revenue (US$, Mn), (2017-2022)
Table 39. Alexza Pharmaceuticals Corporate Summary
Table 40. Alexza Pharmaceuticals Acute Repetitive Seizures Product Offerings
Table 41. Alexza Pharmaceuticals Acute Repetitive Seizures Revenue (US$, Mn), (2017-2022)
Table 42. Veriton Pharma Corporate Summary
Table 43. Veriton Pharma Acute Repetitive Seizures Product Offerings
Table 44. Veriton Pharma Acute Repetitive Seizures Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Acute Repetitive Seizures Segment by Type in 2021
Figure 2. Acute Repetitive Seizures Segment by Application in 2021
Figure 3. Global Acute Repetitive Seizures Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Acute Repetitive Seizures Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Acute Repetitive Seizures Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Repetitive Seizures Revenue in 2021
Figure 8. By Type - Global Acute Repetitive Seizures Revenue Market Share, 2017-2028
Figure 9. By Application - Global Acute Repetitive Seizures Revenue Market Share, 2017-2028
Figure 10. By Region - Global Acute Repetitive Seizures Revenue Market Share, 2017-2028
Figure 11. By Country - North America Acute Repetitive Seizures Revenue Market Share, 2017-2028
Figure 12. US Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Acute Repetitive Seizures Revenue Market Share, 2017-2028
Figure 16. Germany Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 17. France Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Acute Repetitive Seizures Revenue Market Share, 2017-2028
Figure 24. China Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 28. India Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Acute Repetitive Seizures Revenue Market Share, 2017-2028
Figure 30. Brazil Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Acute Repetitive Seizures Revenue Market Share, 2017-2028
Figure 33. Turkey Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Acute Repetitive Seizures Revenue, (US$, Mn), 2017-2028
Figure 37. UCB S.A. Acute Repetitive Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Neurelis Acute Repetitive Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Valeant Pharmaceuticals North America LLC. Acute Repetitive Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Alexza Pharmaceuticals Acute Repetitive Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Veriton Pharma Acute Repetitive Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)